Company intelligence / Profile preview

My DNA Health

Norwich, England, United Kingdom

Ownership: Private
Development stage: Other

Overview

My DNA Health provides clinically validated DNA insights and reporting for precision health, offering both clinical (pharmacogenomics, hereditary risk) and wellness (nutrition, fitness) panels. Clinical utility includes medication optimization and hereditary risk assessment through NGS and array-based testing, with CE-IVD marked and accredited labs in the UK, Australia, and US. No therapeutic products; commercial-stage diagnostics only.

Therapeutic areas: CardiovascularImmunologyEndocrinologyNeurologyRare DiseasesOtherOncology
Modalities: DiagnosticsGenetic testing
Industry: Molecular Diagnostics

Partnerships

University of Glasgow Living Laboratory for Precision MedicineAgena BioscienceGene by Gene (laboratory partnership)Illumina (software/data platform partnership)

Beyond the preview

Go deeper on My DNA Health.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on My DNA Health.

Explore the full profile